EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Cyclosporiasis in Pregnancy: A Narrative Review

Andrew Elimian, Lili S. Wei, Joseph Canterino, Reinaldo Figueroa

American Journal of Perinatology · 2026-10-22

DOI: 10.1055/a-2979-5863 ↗
AbstractBibliografische Angaben

Abstract

Abstract Cyclosporiasis, caused by the protozoan parasite Cyclospora cayetanensis, is an emerging foodborne illness of increasing clinical relevance in both endemic and developed countries. Its specific implications during pregnancy remain poorly characterized. Our objective is to synthesize current evidence on the clinical presentation, diagnosis, treatment, and prevention of cyclosporiasis during pregnancy. This is a narrative review of peer-reviewed literature published between 2012 and 2026, supplemented by guidance from the Centers for Disease Control and Prevention and other major health authorities. Cyclosporiasis presents with prolonged watery diarrhea, profound fatigue, and anorexia, all features of heightened concern during pregnancy, given the risks of dehydration, malnutrition, and preterm labor. Trimethoprim–sulfamethoxazole (TMP–SMX) remains the treatment of choice, but its use requires careful consideration of gestational timing, folate supplementation, and the risk of neonatal hyperbilirubinemia. No highly effective alternatives exist for sulfonamide-allergic patients. There is no evidence of vertical transmission. Cyclosporiasis in pregnancy is a clinically challenging condition requiring prompt recognition and tailored management. Prevention through rigorous food and water hygiene is paramount. TMP–SMX can be used safely with appropriate precautions. Further research is needed to define pregnancy-specific outcomes and treatment protocols.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →